Trends and overview: ELRIG "Robotics and Automation"

Laboratories on the way to end-to-end automation: Robotics, artificial intelligence and automation technology boosted by pandemic

Rising interest in CRISPR treatments

Treatments using CRISPR technology are emerging as one of the hottest medical trends in the United States – and the FDA is doing its best to promote the development.

Stockholm Science City Foundation

Eli Lilly requests re-examination of Alzheimer's drug recommendation

Eli Lilly has requested that the EMA re-examine its opinion on the company's Alzheimer's drug, Kisunla, the agency announced on Friday.

WuXi AppTec, UK Ltd

Lucy Robertshaw: Did you know Stockholm wants to be in top 5 in the world for Life Sciences?

Karolinska Institutet Solna Campus has certainly become the next “Kendall Square”, writes Lucy Robertshaw in a column.

ZEISS Quality Innovation Days

The leading digital event from April 15-19, 2024.

Start-up som utvecklar digital tvilling prisades under EIT Health Summit

Ett biotech-företag, ett medtech-företag och ett företag inom digital hälsa stod på prispallen när EIT Health Catapult avgjordes.

Collaboration for a simpler production of gene therapies launched

A collaboration between universities and companies aims at providing better production methods for the development of gene therapies. The initiative is led by J...

Krönika: Can regulators keep up with innovation?

New technology has increased the understanding of disease mechanisms and enabled approval of products targeting small but specific patient populations; sometime...

Digital Temperature Sensors from ZEISS

New Metrology Expert Tip video.

Uncertainty about the government’s life science work

The government’s national coordinator for life science, Jenni Nordborg, left her position almost four months ago. No one has yet succeeded her, and now question...

Automate E2E Image Analysis Pipelines

ZEISS arivis Pro - Your End-to-End Scientific Image Analysis Software.

Cytel Inc acquires the SDS Group

The multinational statistical software developer and contract research organization Cytel Inc, headquartered in Massachusetts, USA, acquires the Swedish consult...

Major investment in women’s health – for a more equal healthcare system

”The regional differences need to decrease and the long-term supply of midwives and other professions needs to be secured,” write Acko Ankarberg Johansson and D...

New rules for diagnostic products, but who will certify them? “An extreme shortage area”

In less than two weeks, new and stricter EU rules will enter into force for thousands of products used in important diagnoses of, among other things, cancer and...

“A major energy boost for the entire cancer vaccine field”

The development of cancer vaccines has accelerated in recent years. Norwegian Ultimovacs is one of the companies attempting to develop a new type of treatment l...

Anders Blanck about his 17 years at Lif: “The industry is enjoying greater public trust now"

The announcement came as a surprise to those around him, but according to the protagonist himself, the timing was excellent. Anders Blanck is now leaving Lif – ...

Aurevia

Astra Zeneca investerar i franskt genterapibolag

Astra Zeneca gör en ny miljardsatsning inom cell- och genterapier genom ett samarbets- och investeringsavtal med franska Cellectis. Målet är att ta fram nya beh...

No demand for new Covid vaccine – “It will probably be discarded”

So far, just under 6 000 doses of the Covid vaccine from Novavax have been used in Sweden, leaving over 1.4 million doses in stock. “They will probably be disca...

Are you ready for EMC 2024?

Visit ZEISS at Europe’s largest Event dedicated to Microscopy and Imaging.

Pfizer flyttar svenska huvudkontoret till Hagastaden

Läkemedelsjätten Pfizer flyttar sitt svenska huvudkontor till Life City i Hagastaden, som därmed får ännu ett stort life science-företag som hyresgäst.

Gilead står fast vid hivsatsning – trots hotad finansiering

Gilead Sciences planerar fortfarande att leverera sitt hiv-läkemedel till låginkomstländer om det godkänns i USA, trots osäker finansiering efter Trumpadministr...